Stay updated on Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    - Revision: v3.3.2 added and v3.2.0 removed. This is a minor metadata update at the bottom of the page and does not affect the study information.
    Difference
    0.1%
    Check dated 2025-11-26T08:31:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A government funding/operating status notice banner was removed from the page. The core study details and trial information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-19T08:45:57.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Both screenshots depict the same study (NCT03126812) with identical title, sponsor, status, enrollment, and planned interventions; no core content changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-28T08:26:51.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T17:20:23.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Page now shows Results Submitted and Revision: v3.1.0, replacing No Results Posted and Revision: v3.0.2; indicates new results are available and the document version has advanced.
    Difference
    0.7%
    Check dated 2025-09-28T10:11:40.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 instead of v3.0.1, indicating a minor version update. The Back to Top element was removed, a small UI change with little impact on core content.
    Difference
    0.3%
    Check dated 2025-09-14T00:22:10.000Z thumbnail image

Stay in the know with updates to Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.